Related Experiment Video
Updated: Apr 30, 2026
09:50
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
11.3K
Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior
Gabe Haller1, Ping Li2, Caroline Esch2
1Departments of Psychiatry and Genetics, Washington University, St. Louis, Missouri, United States of America.
Plos One
|May 9, 2014
Summary
Genetic variants in CHRNB4 influence nicotine dependence risk. Functional analysis revealed that increased sensitivity to low nicotine concentrations offers protection against developing nicotine dependence.
Area of Science:
- Genetics
- Neuroscience
- Pharmacology
Background:
- Smoking is a leading cause of preventable death globally.
- Genetic variants in nicotinic acetylcholine receptor genes are linked to nicotine dependence risk.
- Previous studies identified rare CHRNB4 variants associated with reduced nicotine dependence risk in African Americans.
Purpose of the Study:
- To investigate the functional effects of rare missense variants in the CHRNB4 gene.
- To integrate functional data into a gene-based association test for nicotine dependence risk.
- To explore the protective role of nicotine sensitivity against nicotine dependence.
Main Methods:
- Pooled sequencing of nicotinic acetylcholine receptor genes (CHRNA5, CHRNA3, CHRNB4, CHRNA6, CHRNB3).
- Co-expression of identified CHRNB4 variants with nicotinic acetylcholine receptor subunits (α3, α4) in human embryonic kidney cells.
- Functional assays including voltage-clamp electrophysiology, qRT-PCR, Western blots, and cell-surface ELISAs.
- Gene-based association testing weighted by functional variant data.
Main Results:
- Ten low-frequency, non-synonymous variants in CHRNB4 were identified.
- Functional analysis demonstrated significant correlations between weighted carrier status and nicotine dependence risk when variants were expressed with the α3 subunit.
- Specifically, acetylcholine EC50 and response to low nicotine concentrations showed significant associations (P < 10^-4).
- Unweighted carrier status did not show significant association with nicotine dependence risk.
Conclusions:
- Functional analysis of genetic variants provides valuable insights into nicotine dependence risk.
- Integrating functional data into genetic studies enhances the identification of significant associations.
- Increased sensitivity to low nicotine concentrations may be a protective factor against nicotine dependence.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:15Cholinergic Receptors: Nicotinic
5.4K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.4K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48